Intestinal angioedema from angiotensin converting enzyme inhibitor. 2019

Valentine Gillion, and Cristina Anca Dragean, and Géraldine Dahlqvist, and Michel Jadoul
Department of Nephrology, Cliniques Universitaires Saint Luc, Brussels, Belgium. Electronic address: valentine.gillion@uclouvain.be.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007579 Jejunal Diseases Pathological development in the JEJUNUM region of the SMALL INTESTINE. Disease, Jejunal,Diseases, Jejunal,Jejunal Disease
D007583 Jejunum The middle portion of the SMALL INTESTINE, between DUODENUM and ILEUM. It represents about 2/5 of the remaining portion of the small intestine below duodenum. Jejunums
D004656 Enalapril An angiotensin-converting enzyme inhibitor that is used to treat HYPERTENSION and HEART FAILURE. Enalapril Maleate,MK-421,MK421,Renitec,Renitek,MK 421,Maleate, Enalapril
D005260 Female Females
D005923 Glomerulosclerosis, Focal Segmental A clinicopathological syndrome or diagnostic term for a type of glomerular injury that has multiple causes, primary or secondary. Clinical features include PROTEINURIA, reduced GLOMERULAR FILTRATION RATE, and EDEMA. Kidney biopsy initially indicates focal segmental glomerular consolidation (hyalinosis) or scarring which can progress to globally sclerotic glomeruli leading to eventual KIDNEY FAILURE. Glomerulonephritis, Focal Sclerosing,Hyalinosis, Segmental Glomerular,Focal Segmental Glomerulosclerosis,Glomerulosclerosis, Focal,Hyalinosis, Segmental,Segmental Glomerular Hyalinosis,Focal Glomerulosclerosis,Focal Sclerosing Glomerulonephritides,Focal Sclerosing Glomerulonephritis,Glomerular Hyalinosis, Segmental,Glomerulonephritides, Focal Sclerosing,Sclerosing Glomerulonephritides, Focal,Sclerosing Glomerulonephritis, Focal,Segmental Glomerulosclerosis, Focal,Segmental Hyalinosis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000799 Angioedema Swelling involving the deep DERMIS, subcutaneous, or submucosal tissues, representing localized EDEMA. Angioedema often occurs in the face, lips, tongue, and larynx. Quincke's Edema,Urticaria, Giant,Angioneurotic Edema,Angioedemas,Angioneurotic Edemas,Edema, Angioneurotic,Edema, Quincke's,Edemas, Angioneurotic,Giant Urticaria,Giant Urticarias,Quincke Edema,Quinckes Edema,Urticarias, Giant
D000806 Angiotensin-Converting Enzyme Inhibitors A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility. ACE Inhibitor,ACE Inhibitors,Angiotensin Converting Enzyme Inhibitor,Angiotensin I-Converting Enzyme Inhibitor,Angiotensin-Converting Enzyme Inhibitor,Kininase II Inhibitor,Kininase II Inhibitors,Angiotensin I-Converting Enzyme Inhibitors,Angiotensin-Converting Enzyme Antagonists,Antagonists, Angiotensin-Converting Enzyme,Antagonists, Kininase II,Inhibitors, ACE,Inhibitors, Angiotensin-Converting Enzyme,Inhibitors, Kininase II,Kininase II Antagonists,Angiotensin Converting Enzyme Antagonists,Angiotensin Converting Enzyme Inhibitors,Angiotensin I Converting Enzyme Inhibitor,Angiotensin I Converting Enzyme Inhibitors,Antagonists, Angiotensin Converting Enzyme,Enzyme Antagonists, Angiotensin-Converting,Enzyme Inhibitor, Angiotensin-Converting,Enzyme Inhibitors, Angiotensin-Converting,II Inhibitor, Kininase,Inhibitor, ACE,Inhibitor, Angiotensin-Converting Enzyme,Inhibitor, Kininase II,Inhibitors, Angiotensin Converting Enzyme

Related Publications

Valentine Gillion, and Cristina Anca Dragean, and Géraldine Dahlqvist, and Michel Jadoul
January 2015, Internal medicine (Tokyo, Japan),
Valentine Gillion, and Cristina Anca Dragean, and Géraldine Dahlqvist, and Michel Jadoul
January 2020, Advanced emergency nursing journal,
Valentine Gillion, and Cristina Anca Dragean, and Géraldine Dahlqvist, and Michel Jadoul
January 2020, Advanced emergency nursing journal,
Valentine Gillion, and Cristina Anca Dragean, and Géraldine Dahlqvist, and Michel Jadoul
October 2012, The Journal of emergency medicine,
Valentine Gillion, and Cristina Anca Dragean, and Géraldine Dahlqvist, and Michel Jadoul
May 2021, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne,
Valentine Gillion, and Cristina Anca Dragean, and Géraldine Dahlqvist, and Michel Jadoul
August 2021, Anesthesiology,
Valentine Gillion, and Cristina Anca Dragean, and Géraldine Dahlqvist, and Michel Jadoul
February 2022, Emergency medicine clinics of North America,
Valentine Gillion, and Cristina Anca Dragean, and Géraldine Dahlqvist, and Michel Jadoul
January 2013, Cutis,
Valentine Gillion, and Cristina Anca Dragean, and Géraldine Dahlqvist, and Michel Jadoul
February 2015, The American journal of medicine,
Valentine Gillion, and Cristina Anca Dragean, and Géraldine Dahlqvist, and Michel Jadoul
November 2006, Immunology and allergy clinics of North America,
Copied contents to your clipboard!